Yifan Pharmaceutical (002019.SZ) announced first-half results, with net profit of 304 million yuan to mother, an increase of 19.91% over the previous year

According to Zhitong Finance App, Yifan Pharmaceutical (002019.SZ) released its 2025 semi-annual report. During the reporting period, the company achieved revenue of 2,635 billion yuan, an increase of 0.11% over the previous year. Achieved net profit of 304 million yuan attributable to shareholders of listed companies, an increase of 19.91% over the previous year. Achieved net profit of 237 million yuan after deducting non-recurring profit and loss attributable to shareholders of listed companies, an increase of 32.21% over the previous year. Basic earnings per share were $0.25.